Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database
Barritt, et al.
π bit.ly/4kQDarW
@jasmohanbajaj.bsky.social
Liver specialist at Virginia Commonwealth University and Richmond VAMC . Interested in the brain liver gut axis. Co-EIC of Am J Gastro. Posts are personal.
Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database
Barritt, et al.
π bit.ly/4kQDarW
It's finally here! Consensus #ACLF & #cirrhosis organ failure definitions. ‡οΈ
pubmed.ncbi.nlm.nih.gov/40499736/
Why? We need to speak the same language re #ACLF
How? Multi-country consensus panels
Result? Harmonized definitions & Β research agenda @aasldnews.bsky.social @easlnews.bsky.social
Amazing panel discussions at the end of the EASL-ESCMID session at #EASLCongress 2025
#AMR, #liver, #cirrhosis
@easlnews.bsky.social
@escmid.bsky.social
@esgvh.bsky.social
@oana-sandulescu.bsky.social
@jasmohanbajaj.bsky.social
In the #RedJournal:
Supplement β Demystifying Carbohydrate Maldigestion: A Clinical Review
Brooks D. Cash, MD, FACG; Daksesh Patel, DO & Kate Scarlata, MPH, RDN
π bit.ly/3GhUN4q
@katescarlata.bsky.social @jasmohanbajaj.bsky.social
Explore the April issue of the #RedJournal!
Featuring the new β ACG Guideline on Gastric Premalignant Conditions and β US Multi-Society Task Force on CRC consensus recommendations on bowel prep for colonoscopy.
π bit.ly/AmJGastro
@jasmohanbajaj.bsky.social
In the π#RedJournal:
Timing of Direct Oral Anticoagulants Resumption Following Colorectal Endoscopic Submucosal Dissection: A Nationwide Study in Japan
Ichita, et al.
π bit.ly/4iRPbvM
Recent study:β¬οΈ #daptomycin resist w #rifaximin.
But does this impact outcomes in #cirrhosis?
In VA & TriNetX we found no impact of rifaximin on dapt users on
π30-day mortality
πLT
πsepsis dev
πlinezolid use
β
@amergastroassn.bsky.social β‘οΈ pubmed.ncbi.nlm.nih.gov/40122471/ @absteward.bsky.social
In the π#RedJournal:
The Red Section: Guidelines in Practice β Alcohol-Associated Liver Disease
Loretta L. Jophlin, MD, PhD*; Ashwani K. Singal, MD, MS, FACG* & Vijay H. Shah, MD, FACG
π bit.ly/4kPSMwk
@jasmohanbajaj.bsky.social
In #CTGjournal:
Secondary SBP Prophylaxis is Associated with a Higher Rate of Non-SBP Infections in Two US-based National Cirrhosis Cohorts
Silvey, et al.
β‘οΈ bit.ly/428BEKH
@jasmohanbajaj.bsky.social
After five decades, steroid dosing in AAH is revisited: Tapered prednisolone proves superior in reducing infections.
#STASH trial @jasmohanbajaj.bsky.social @juanpabloarab.bsky.social @ebtapper.bsky.social @tonybreu.bsky.social
@blaneymd.medsky.social
journals.lww.com/ajg/abstract... #liversky
Unnecessary #antibiotics: #SBP prophylaxis in #cirrhosis β¬οΈ #SBP & other infections! Esp #UTIs w similarπ¦
latest from VA & Trinetx ‡οΈ
pubmed.ncbi.nlm.nih.gov/40062879/
50% of US βuse SBPProph..should we all follow & β¬οΈ #AMR?
@absteward.bsky.social @amcollegegastro.bsky.social @ebtapper.bsky.social
Explore the March issue of The American Journal of #Gastroenterology!
π bit.ly/AmJGastro
@jasmohanbajaj.bsky.social @andrewmmoon.bsky.social
Dedicated to #ColorectalCancerScreening!
ACG's Board of Trustees under the leadership of President Dr. @amyoxentenkomd.bsky.social
These visionary leaders ensure ACG aligns its actions & priorities with its mission & vision
#ColorectalCancerAwarenessMonth #DressinBlueDay #ACGfamily #GastroSky
Thanks #CDDW #CLM Chris Rose & Premsyl Bercik for the invite to speak in a beautiful but freezing Quebec city on #HE #microbes & #gutbrainaxis. Excellent joint session with #microbiology & #gi expertise. π¨π¦ warmth shone thru despite the polar vortex!! @vculiver.bsky.social
02.03.2025 14:30 β π 8 π 2 π¬ 2 π 0ASCI member @jasmohanbajaj.bsky.social et al. show that fecal transplant ameliorates a source of cirrhosis progression.
27.02.2025 16:13 β π 1 π 2 π¬ 0 π 0In the π#RedJournal:
Update on Newly Federal Drug Administration-Approved Drug, Resmetirom: A Practical Perspective
A. Sidney Barritt, IV, MD, MSCR, FACG & Jonathan G. Stine, MD, MSc
π bit.ly/438oCOq
@sidbarritt4.bsky.social @jonathanstinemd.bsky.social
In the π#RedJournal:
The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory Ascites
Wong, et al.
π bit.ly/3QsoPnM
@jasmohanbajaj.bsky.social
Please check out this powerful statement re: #NIH by @kerialthoff.bsky.social :
π₯: www.instagram.com/reel/DF3kmec...
Then go here to check out the impact for *your* state:
π°: www.unitedformedicalresearch.org/nih-in-your-...
& Contact your US Sen.s/Rep.!:
βοΈ : www.usa.gov/elected-offi...
Metabolic risk factors are increasingly important drivers of primary liver cancer but.... it's complicated
Joseph Ahn lays out the power and perils of Global Burden of Disease data in this editorial in @amcollegegastro.bsky.social #AJG editorial
journals.lww.com/ajg/fulltext...
#GISky #LiverSky
π @paulsaxmd.bsky.social for the invitation to write this from a #liversky and #IDsky perspective @cidjournal.bsky.social
Totally agree the approach needs to shift! @vculiver.bsky.social @idsainfo.bsky.social @easlnews.bsky.social @varesearch.bsky.social
Wait. ONE lousy trial is the major reason for spontaneous bacterial peritonitis prophylaxis?! Thanks to @paulsaxmd.bsky.social for this!
#IDSky #Medsky
academic.oup.com/cid/advance-...
The February Issue of The American Journal of #Gastroenterology is now available!
Explore this month's articles, including the new joint ACG-@asgeendo.bsky.social Quality Indicators for Upper GI Endoscopy!
πbit.ly/AmJGastro
@jasmohanbajaj.bsky.social
π for highlighting our commentary @cidjournal.bsky.social
Need to re-evaluate these practices due to β¬οΈ
- #amr burden
- C difficile & #antibiotic adverse events
- costs
#liversky #gisky @varesearch.bsky.social @idsainfo.bsky.social @amcollegegastro.bsky.social @easlnews.bsky.social
ACG is proud to be hosting a summit on AI in GI, covering responsible, practical, and sustainable applications to improve clinical practice and patient outcomes.
Thanks to our many experts and innovators for helping shape the future of AI in our field! #AIinGI #GastroSky
Pts w #Hepaticencephalopathy get a raw deal for #Livertransplant. Does MELD3.0 help?
π we need to do more!
In @varesearch.bsky.social #cirrhosis pts @amcollegegastro.bsky.social
πinpt HE adds >4-5 MELD3.0 points for 90D & 6-7 for 1Y mortality
πHE needs priority!‡οΈ
pubmed.ncbi.nlm.nih.gov/39836914/
Check out @nytimes.com interview of experts re: #wellness my tip? Coffee for the win!! Liver brain and microbes all benefit from this
Check it out below
www.nytimes.com/interactive/... @vculiver.bsky.social @amcollegegastro.bsky.social @ebtapper.bsky.social @easlnews.bsky.social
βNEW! #RedJournal Special Issue on π₯ Inflammation in Digestive Diseases π₯
From Co-EICs Dr. Jasmohan Bajaj & Dr. Millie Long:
"The 'Red Journal' is on fire this month, to change how you think about inflammation in practice."
π bit.ly/AmJGastro
@jasmohanbajaj.bsky.social @andrewmmoon.bsky.social
NEW! ACG Clinical Guideline:
Management of Eosinophilic Esophagitis #EoE
Dellon, et al.
πRead bit.ly/acg-eoe-2025
ποΈListen bit.ly/ajg-podcast-...
πHighlights bit.ly/acg-eoe-guid...
#GastroSky #MedSky
@jasmohanbajaj.bsky.social @andrewmmoon.bsky.social @cneumsma.bsky.social
Delighted to share our recent review in @AmJGastro Clinical Implications of Inflammation in Patients With Cirrhosis journals.lww.com/ajg/fulltext... @jasmohanbajaj.bsky.social
02.01.2025 17:06 β π 7 π 1 π¬ 0 π 0ποΈSAVE THE DATE! #ACG2025 Annual Scientific Meeting & Postgraduate Course
π΅Phoenix, AZ October 24-29, 2025
Timely and relevant postgraduate course offerings and innovative clinical science in #Gastroenterology #Hepatology and #Endoscopy!
#GastroSky #LiverSky #EndoscopySky